Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Wyeth |
---|---|
Information provided by: | Wyeth |
ClinicalTrials.gov Identifier: | NCT00137345 |
The purpose of this study is to determine if one drug is superior to another with regard to safety and the preservation of renal function after a kidney transplant.
Condition | Intervention | Phase |
---|---|---|
Kidney Transplant |
Drug: sirolimus |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Open-Label, Comparative Evaluation of the Safety and Efficacy of Sirolimus Versus Cyclosporine When Combined in a Regimen Containing Basiliximab, Mycophenolate Mofetil, and Corticosteroids in Primary De Novo Renal Allograft Recipients |
Estimated Enrollment: | 500 |
Study Start Date: | June 2005 |
Ages Eligible for Study: | 13 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study Director: | Medical Monitor | Wyeth |
Principal Investigator: | Trial Manager | For Germany, MedInfoDEU@wyeth.com |
Principal Investigator: | Trial Manager | For Norway, Sweden, MedInfoNord@wyeth.com |
Principal Investigator: | Trial Manager | For Australia, Taiwan, medinfo@wyeth.com |
Principal Investigator: | Trial Manager | For Austria, WPVIMED@wyeth.com |
Principal Investigator: | Trial Manager | For Italy, Greece, decresg@wyeth.com |
Principal Investigator: | Trial manager | For Hungary, WPBUMED@wyeth.com |
Principal Investigator: | Trial Manager | For Turkey, Erisc@wyeth.com |
Principal Investigator: | Trial Manager | For South Africa, ZAFinfo@wyeth.com |
Principal Investigator: | Trial Manager | For Argentina, Chile, scheima@wyeth.com, rendop@wyeth.com |
Principal Investigator: | Trial Manager | For UK, ukmedonfo@wyeth.com |
Principal Investigator: | Trial Manager | For Switzerland, med@wyeth.com |
Study ID Numbers: | 0468H1-318 |
Study First Received: | August 25, 2005 |
Last Updated: | September 6, 2006 |
ClinicalTrials.gov Identifier: | NCT00137345 |
Health Authority: | European Union: European Medicines Agency; United States: Food and Drug Administration |
Randomized controlled trial Clinical Trial Phase III Drug therapy Immunosuppression |
Treatment outcome Kidney transplantation Kidney function tests |
Sirolimus Basiliximab Cyclosporine Clotrimazole |
Miconazole Tioconazole Mycophenolate mofetil Cyclosporins |
Anti-Bacterial Agents Anti-Infective Agents Immunologic Factors Molecular Mechanisms of Pharmacological Action Antineoplastic Agents Antifungal Agents |
Therapeutic Uses Physiological Effects of Drugs Enzyme Inhibitors Antibiotics, Antineoplastic Immunosuppressive Agents Pharmacologic Actions |